163 related articles for article (PubMed ID: 20034479)
1. Presenilin 1-related alterations in DNA integrity in a transgenic mouse model of Alzheimer's disease.
Michelsen KA; Korr H; Steinbusch HW; Schmitz C
Brain Res; 2010 Feb; 1316():139-44. PubMed ID: 20034479
[TBL] [Abstract][Full Text] [Related]
2. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
[TBL] [Abstract][Full Text] [Related]
3. Changes in bladder innervation in a mouse model of Alzheimer's disease.
Biallosterski BT; de Wachter SG; van Koeveringe GA; van Kerrebroeck PE; de Vente J; Mulder MT; Gillespie JI
J Chem Neuroanat; 2010 May; 39(3):204-10. PubMed ID: 20025962
[TBL] [Abstract][Full Text] [Related]
4. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS.
Woo DC; Lee SH; Lee DW; Kim SY; Kim GY; Rhim HS; Choi CB; Kim HY; Lee CU; Choe BY
Behav Brain Res; 2010 Jul; 211(1):125-31. PubMed ID: 20307581
[TBL] [Abstract][Full Text] [Related]
5. Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP + PS1 transgenic mouse brains.
Amritraj A; Hawkes C; Phinney AL; Mount HT; Scott CD; Westaway D; Kar S
Neurobiol Aging; 2009 Jan; 30(1):54-70. PubMed ID: 17561313
[TBL] [Abstract][Full Text] [Related]
6. Functional phenotype in transgenic mice expressing mutant human presenilin-1.
Barrow PA; Empson RM; Gladwell SJ; Anderson CM; Killick R; Yu X; Jefferys JG; Duff K
Neurobiol Dis; 2000 Apr; 7(2):119-26. PubMed ID: 10783295
[TBL] [Abstract][Full Text] [Related]
7. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE
J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896
[TBL] [Abstract][Full Text] [Related]
8. APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1.
Jankowsky JL; Slunt HH; Gonzales V; Jenkins NA; Copeland NG; Borchelt DR
Neurobiol Aging; 2004 Aug; 25(7):885-92. PubMed ID: 15212842
[TBL] [Abstract][Full Text] [Related]
9. Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: effects of APP/PS1 genotype and ovariectomy.
Miettinen R; Riedel A; Kalesnykas G; Kettunen HP; Puoliväli J; Soininen H; Arendt T
J Chem Neuroanat; 2005 Oct; 30(2-3):105-18. PubMed ID: 16081247
[TBL] [Abstract][Full Text] [Related]
10. Noggin and BMP4 co-modulate adult hippocampal neurogenesis in the APP(swe)/PS1(DeltaE9) transgenic mouse model of Alzheimer's disease.
Tang J; Song M; Wang Y; Fan X; Xu H; Bai Y
Biochem Biophys Res Commun; 2009 Jul; 385(3):341-5. PubMed ID: 19463786
[TBL] [Abstract][Full Text] [Related]
11. Neurons overexpressing mutant presenilin-1 are more sensitive to apoptosis induced by endoplasmic reticulum-Golgi stress.
Terro F; Czech C; Esclaire F; Elyaman W; Yardin C; Baclet MC; Touchet N; Tremp G; Pradier L; Hugon J
J Neurosci Res; 2002 Aug; 69(4):530-9. PubMed ID: 12210846
[TBL] [Abstract][Full Text] [Related]
12. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
13. Decreased Abeta secretion by cells expressing familial Alzheimer's disease-linked mutant presenilin 1.
Shimojo M; Sahara N; Murayama M; Ichinose H; Takashima A
Neurosci Res; 2007 Mar; 57(3):446-53. PubMed ID: 17210196
[TBL] [Abstract][Full Text] [Related]
14. Excitatory synaptic transmission is depressed in cultured hippocampal neurons of APP/PS1 mice.
Priller C; Mitteregger G; Paluch S; Vassallo N; Staufenbiel M; Kretzschmar HA; Jucker M; Herms J
Neurobiol Aging; 2009 Aug; 30(8):1227-37. PubMed ID: 18077058
[TBL] [Abstract][Full Text] [Related]
15. The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice.
Ren K; King MA; Liu J; Siemann J; Altman M; Meyers C; Hughes JA; Meyer EM
Neuroscience; 2007 Aug; 148(1):230-7. PubMed ID: 17640819
[TBL] [Abstract][Full Text] [Related]
16. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice.
Hartmann J; Erb C; Ebert U; Baumann KH; Popp A; König G; Klein J
Neuroscience; 2004; 125(4):1009-17. PubMed ID: 15120860
[TBL] [Abstract][Full Text] [Related]
17. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease.
El Tannir El Tayara N; Delatour B; Le Cudennec C; Guégan M; Volk A; Dhenain M
Neurobiol Dis; 2006 Apr; 22(1):199-208. PubMed ID: 16337798
[TBL] [Abstract][Full Text] [Related]
18. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
[TBL] [Abstract][Full Text] [Related]
19. Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
Kurt MA; Davies DC; Kidd M; Duff K; Rolph SC; Jennings KH; Howlett DR
Exp Neurol; 2001 Sep; 171(1):59-71. PubMed ID: 11520121
[TBL] [Abstract][Full Text] [Related]
20. The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease.
Hamilton A; Holscher C
Brain Res; 2012 Apr; 1449():83-93. PubMed ID: 22418058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
